Is Enliven Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 08:26 PM IST
share
Share Via
As of September 11, 2025, Enliven Therapeutics, Inc. has a mildly bearish technical outlook, with bearish indicators from MACD, moving averages, and Bollinger Bands, and has underperformed the S&P 500 year-to-date and over the past year.
As of 11 September 2025, the technical trend for Enliven Therapeutics, Inc. has changed from bearish to mildly bearish. The MACD indicates a bearish stance on both weekly and monthly time frames, while the RSI shows no signal for either period. Bollinger Bands are sideways on the weekly and bearish on the monthly, and moving averages are bearish on the daily. KST and Dow Theory both reflect a mildly bearish outlook on the weekly, with Dow Theory showing no trend on the monthly.

In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of -11.44% compared to the S&P 500's 12.22%, and a one-year return of -8.43% versus 17.14%. Overall, the current technical stance is mildly bearish.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News